Operator of a biotechnology company. The company develops drugs and technologies for the treatment of HIV/AIDS. The company also focuses on development of treatments for cancer, hepatitis C and other infectious diseases.
What you see here scratches the surface
We’ll help you find what you need
This information is available in the PitchBook Platform. To explore Tibotec-Virco‘s full profile, request access.
© 2021 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.